Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies - sprookjes - yvandenbroek - TriplyDB

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

http://www.wikidata.org/entity/Q28273319

about

Regulation of cardiac proteasomes by ubiquitination, SUMOylation, and beyond New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart The ubiquitin-proteasome system and cardiovascular disease Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies Research priorities in sarcomeric cardiomyopathies Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy Phenotype Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice Defective proteolytic systems in Mybpc3-targeted mice with cardiac hypertrophy Protein quality control and metabolism: bidirectional control in the heart The ubiquitin proteasome system and myocardial ischemia Thin filament mutations: developing an integrative approach to a complex disorder A comparative study of improvements Pre-filter methods bring on feature selection using microarray data Proteasomal and lysosomal protein degradation and heart disease.Mutations in proteasome-related genes are associated with thyroid hemiagenesis Atrogin-1 deficiency promotes cardiomyopathy and premature death via impaired autophagy.The ubiquitin proteasome system in human cardiomyopathies and heart failure.Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.A heart that beats for 500 years: age-related changes in cardiac proteasome activity, oxidative protein damage and expression of heat shock proteins, inflammatory factors, and mitochondrial complexes in Arctica islandica, the longest-living noncolon Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice.Pregnancy is associated with decreased cardiac proteasome activity and oxidative stress in mice.Enhancement of proteasome function by PA28α overexpression protects against oxidative stress.Sarcomere mutation-specific expression patterns in human hypertrophic cardiomyopathy Role of the ubiquitin-proteasome system in cardiac dysfunction of adipose triglyceride lipase-deficient mice A hypertrophic cardiomyopathy-associated MYBPC3 mutation common in populations of South Asian descent causes contractile dysfunction Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice Lysine ubiquitination and acetylation of human cardiac 20S proteasomes.Proteasome functional insufficiency in cardiac pathogenesis.Impact of leucine supplementation on exercise training induced anti-cardiac remodeling effect in heart failure mice.The COP9 signalosome and cullin-RING ligases in the heart Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway.Differential regulation of proteasome function in isoproterenol-induced cardiac hypertrophy Post-translational modification of cardiac proteasomes: functional delineation enabled by proteomics.Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice.New frontiers in heart hypertrophy during pregnancy.Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy Cardiac systolic dysfunction in doxorubicin-challenged rats is associated with upregulation of MuRF2 and MuRF3 E3 ligases Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways.

P2860

Q26859368-B7242FFD-64FB-48CC-8D67-EE285A6190AE Q26865574-CA28B385-7C75-496A-8993-09052845A758 Q27021582-694E6681-EB5F-4359-BB8D-9CBD282D695D Q27026951-5B867039-A471-4977-BD91-3F8450C1E540 Q27694507-E3F33B27-16B8-43EE-8186-6E5C555D7560 Q28066435-627C2680-EEE3-4559-9526-02688F6F62F7 Q28084015-B7277BAC-20B3-4CEB-980F-010BCD90F879 Q28252819-9E44826B-1BD9-4261-8BE7-89BD5CB0B6C1 Q28255924-06D00685-7084-4E3C-9E1C-5F15DD8D26C1 Q28256472-9569ACF2-1BBF-4FEF-A8B4-7B0562F3C222 Q28280898-67125733-0BD4-4628-9208-F571C2D47ABC Q28307606-CDF0C7B4-6006-400D-B90B-96776D6DEBE7 Q30919855-F2E76B44-0630-4639-8656-3CE8D43AC58A Q33573707-AD217633-195D-46E5-A437-B1A3B6D331EA Q33575777-3304D103-C8B1-4E61-9749-08B69CB38FE5 Q33685877-4A913BB9-F896-4BAE-B15E-FB54D6222DDF Q33816688-EE6F572A-AB64-4E64-B118-7BAC83BD972B Q33907456-CF51DBCF-BB65-4608-9A6F-FCF79C7BD28E Q34338236-EC6A229D-60AD-4BF0-96BC-287F1C23B47F Q34392563-95ACDF4C-FCFF-4ED9-B72E-4B4C905F6F3B Q34474447-64E7D99B-241C-42A4-B5D2-8ED3678B6E90 Q34481968-92C99E1B-6342-4F3C-8531-9794B3CBB6DD Q34592321-A45D5E0B-B88B-47B8-9275-3F52F9014431 Q34626001-09B0BA49-EA00-41E7-96E8-78697A583E1D Q34680942-3A1CBF0B-38FC-4C09-85BC-D38703D0C3CC Q35126714-2C4C19A1-6474-4EF8-8B0C-85071FB32A3C Q35187068-DD76D714-E3DB-4F2F-B535-7DD4014F92CF Q35193622-0A6E5E46-E342-451A-92FF-0A52924C6C86 Q35601400-2EAAB34B-BE50-4E6A-BEB4-4F7B80DEC54D Q35658207-38B2646A-6FBC-466C-812F-11385E3761DB Q35659448-938085BC-06F2-462F-B45C-D3DF10D307F8 Q35895152-7B6E599E-721B-4568-877A-D2E7FBF66D4A Q35990041-A738DBED-441B-4F35-AE86-0783D47B3A15 Q36115334-4AF9725F-22BE-48AB-AA45-86BB8FAC827C Q36184878-32C9D897-F1F7-467B-A74E-671D1BCDE7B3 Q36190273-B6E1CC09-48A8-4531-B57B-CD0A666FA25F Q36647124-78451DAD-77EA-4684-9A26-68F99113A9C4 Q36772298-BEB897A9-4015-407C-AD5C-DA991B29AB26 Q36784081-CD7E44AF-2614-4EF8-9E9C-0B6A63E6AB83 Q36824742-1B593C54-8FFA-4081-9910-D5752C79E857

P2860

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

http://www.wikidata.org/entity/Q28273319

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@ast

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@en

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@nl

type

label

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@ast

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@en

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@nl

prefLabel

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@ast

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@en

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@nl

P1433

Q28273319-223C3E14-B8C5-489D-B16E-F3C1B93BA2F6

P1476

Q28273319-E81751C2-AB8A-49AF-8779-0992E6FE39D9

P2093

Q28273319-192941C8-004E-4CC2-8AEA-4FA6AC72EA1D

Q28273319-3684A714-46E6-495B-B785-8EF750EB0F31

Q28273319-63F68EF1-4B26-4395-A234-36974015E79D

Q28273319-78D1CF16-CA72-4EF8-8853-737CA4F800E0

Q28273319-85D89986-14E7-4484-9301-81E5AAB763F6

Q28273319-C7370653-D756-4F55-BB59-A2986BAFF79A

Q28273319-FEDAFF31-D227-4529-8FBB-44E692DD676A

P2860

Q28273319-09C823F7-506A-4996-BC6F-DC056670D0AF

Q28273319-0B039263-85EF-4B5D-B343-BABFF8CCFC20

Q28273319-149EADA2-E1F1-453A-8EFB-A34F7506A08A

Q28273319-16E0C392-E15C-4E67-9BB3-F33AE868B5E1

Q28273319-187C3F15-610E-43E6-B595-AF5DF6FAA888

Q28273319-238B5B18-7CCD-4920-BEC0-DEC1C8F202B3

Q28273319-28016524-4236-4D4D-8392-B7A3CD442CE9

Q28273319-28D6D45E-C328-404C-8BD6-7BA48A70B518

Q28273319-2CF98913-8869-4544-A5C6-E15AFE2FFCD7

Q28273319-34F1EBE2-F2CC-4F66-AEC1-C25E7FA5A6EB

P304

Q28273319-B187DFA1-14C4-4DCA-843C-1665F267012C

P31

Q28273319-7FE905C2-DA0B-4CA7-B7D5-75D5F68E8510

P3181

Q28273319-6627D3DD-04CB-4A33-BF0B-19729289DDDE

P356

Q28273319-AF82F91A-A194-457A-813E-771DF1D82BB4

P407

Q28273319-0C109F05-8CEF-4021-828B-70B2EAF418DA

P433

Q28273319-ECBFCDF5-F413-4F86-A7EB-866A790DE406

P478

Q28273319-32C24020-4390-4E21-B23A-BC0E68AE2D5E

P50

Q28273319-2CAC2C2C-AA60-4BBE-B2D7-3F61F89D7C7A

Q28273319-FEACCA17-CE15-4422-8E97-7CF06C03CDE6

P577

Q28273319-7F1D0EA2-79C8-42E4-9966-E45950206079

P698

Q28273319-0A2AF124-D8E6-4A9C-9DC3-A14D3906ABE8

P921

Q28273319-8979F778-DEED-46BD-8769-F73F00C0CC9F

P932

Q28273319-68773ABD-B6A4-4656-81F7-A14782534C95

P3181

P356

CIRCULATIONAHA.109.904557

P1433

P1476

Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies

@en

P2093

David B Dyke

http://www.w3.org/2001/XMLSchema#string

Frank Davis

http://www.w3.org/2001/XMLSchema#string

Jaime M Predmore

http://www.w3.org/2001/XMLSchema#string

Margaret V Westfall

http://www.w3.org/2001/XMLSchema#string

Ping Wang

http://www.w3.org/2001/XMLSchema#string

Saul R Powell

http://www.w3.org/2001/XMLSchema#string

Sharlene M Day

http://www.w3.org/2001/XMLSchema#string

P2860

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

Proteasome function is regulated by cyclic AMP-dependent protein kinase through phosphorylation of Rpt6

Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy

Hyperubiquitination of proteins in dilated cardiomyopathy

Impairment of the ubiquitin-proteasome system by truncated cardiac myosin binding protein C mutants

Regulation of murine cardiac 20S proteasomes: role of associating partners

The ubiquitin-proteasome system and its role in inflammatory and autoimmune diseases

Differential roles of the COOH termini of AAA subunits of PA700 (19 S regulator) in asymmetric assembly and activation of the 26 S proteasome

Mapping the murine cardiac 26S proteasome complexes

Impairment of the ubiquitin-proteasome system by protein aggregation

P304

997-1004

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2597489

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/CIRCULATIONAHA.109.904557

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Francis D. Pagani

Sarah N Bartolone

P577

2010-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20159828

http://www.w3.org/2001/XMLSchema#string

P921

ubiquitin-proteasome system

P932

2857348

http://www.w3.org/2001/XMLSchema#string